AngioSoma (SOAN) Stock Price, News & Analysis

Company Overview

AngioSoma, Inc. was a development-stage biopharmaceutical company focused on researching and developing therapies for cancer and vascular diseases. Publicly available information about its specific products, clinical programs, operations, and leadership is limited.

The company was associated with the OTC Markets under the symbol SOAN. Reliable current information regarding its commercial activities, geographic reach, and management is not readily available.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 6.74 million shs
• Market Capitalization: $32.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SOAN
• CIK: 1502152
• Web: angiosoma.com
• Phone: 832 781 8521
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$540 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -1,245.34%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.29
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 476,833,000
• Free Float: N/A
• Market Cap: $32.57 million
• Optionable: Not Optionable
• Beta: -0.46